For research use only
| Cat No. | ABC-SC0019T |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Foreskin |
| Disease | Normal |
| Storage | Liquid Nitrogen |
iPSC (induced Pluripotent Stem cells) reprogrammed from human Multipotent Stem Cells.
HighQC™ Human iPSCs From Foreskin Fibroblasts (Multipotent Stem Cell) are induced pluripotent stem cells reprogrammed from human foreskin fibroblasts. The cell line was generated via episomal reprogramming using a proprietary mix of vectors, containing OCT4, SOX2, KLF4, p53 antisense, and EBNA-1. It was validated for pluripotency based on classical colony morphology, alkaline phosphatase expression, and expression of key pluripotency markers including SSEA-4. The cell line exhibits classical pluripotent stem cell morphology and robust growth. It possesses the capacity to differentiate into multiple but lineage-restricted cell types, characteristic of multipotent behavior under specific induction conditions. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human IPSC From Foreskin Fibroblast (Multipotent Stem Cell), Human iPSC-Fib-MSC, hIPSC-Fib-MSC, Human Foreskin Fibroblast Derived Multipotent iPSC |
| Species | Human |
| Cat.No | ABC-SC0019T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Foreskin |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
HighQC™ Human iPSC From Foreskin Fibroblasts (Multipotent Stem Cell) serves as a highly standardized cellular tool for in vitro disease modeling, and cell lineage studies. This cell line enables the study of molecular mechanisms underlying human developmental disorders and tissue regeneration processes. For example, by differentiating these iPSCs into disease-relevant cell types, researchers can model pathological phenotypes and validate candidate compounds at a cellular level. This supports translational research into tissue engineering and the validation of regenerative strategies.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).